comparemela.com
Home
Live Updates
Johnson & Johnsons Drug Seltorexant Aces Late-Stage Depression Trial - Johnson & Johnson (NYSE:JNJ) : comparemela.com
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial - Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depressive disorder with insomnia.
Related Keywords
United States ,
American ,
Johnson Johnsonjnjannounced ,
American Society Of Clinical Psychopharmacology ,
Johnson ,
American Society ,
Clinical Psychopharmacology ,
Numab Therapeutics ,
comparemela.com © 2020. All Rights Reserved.